Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 22, 2009
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma
Benoit Blanchet, Monika Hurtova, Françoise Roudot-Thoraval, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 11, 2008
The use of proteome similarity for the qualitative and quantitative profiling of reperfused myocardium
Johannes P C Vissers, Sandrine Pons, Anne Hulin, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2017
Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii
Christine Robin, Minh Patrick Lê, Giovanna Melica, et al.
The Journal of Investigative Dermatology
|
January 22, 2017
Are Idiopathic Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone
Cynthia Haddad, Olivier Chosidow, Laurence Valeyrie-Allanore, et al.
World Journal of Gastroenterology
|
November 4, 2017
Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats
Salim Hamdani, Allan Thiolat, Sina Naserian, et al.
British Journal of Pharmacology
|
February 20, 2016
New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis
Jérémy Rocca, Sylvie Manin, Anne Hulin, et al.
Plos One
|
April 18, 2024
Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Plos One
|
February 12, 2025
Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Haematologica
|
December 6, 2006
Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
Mariane de Montalembert, Dora Bachir, Anne Hulin, et al.
JHEP Reports : Innovation in Hepatology
|
October 20, 2023
The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia-reperfusion injury via mitoprotection
Amel Kheyar, Nazim Ahnou, Abdelhakim Ahmed-Belkacem, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 22, 2009
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma
Benoit Blanchet, Monika Hurtova, Françoise Roudot-Thoraval, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 11, 2008
The use of proteome similarity for the qualitative and quantitative profiling of reperfused myocardium
Johannes P C Vissers, Sandrine Pons, Anne Hulin, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2017
Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii
Christine Robin, Minh Patrick Lê, Giovanna Melica, et al.
The Journal of Investigative Dermatology
|
January 22, 2017
Are Idiopathic Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone
Cynthia Haddad, Olivier Chosidow, Laurence Valeyrie-Allanore, et al.
World Journal of Gastroenterology
|
November 4, 2017
Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats
Salim Hamdani, Allan Thiolat, Sina Naserian, et al.
British Journal of Pharmacology
|
February 20, 2016
New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis
Jérémy Rocca, Sylvie Manin, Anne Hulin, et al.
Plos One
|
April 18, 2024
Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Plos One
|
February 12, 2025
Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Keyvan Razazi, Enora Berti, Jerome Cecchini, et al.
Haematologica
|
December 6, 2006
Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease
Mariane de Montalembert, Dora Bachir, Anne Hulin, et al.
JHEP Reports : Innovation in Hepatology
|
October 20, 2023
The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia-reperfusion injury via mitoprotection
Amel Kheyar, Nazim Ahnou, Abdelhakim Ahmed-Belkacem, et al.
Page
of 8